Expect prior authorization requests
Not just another telehealth company shipping out a standard dose and hoping for the best, but a platform built around personalized dosing protocols, weekly provider check-ins, and a clinical model that actually has published research behind it
Recent studies have demonstrated that GLP-1 therapy improves NK cell cytotoxicity
Therefore unless you already have a seizure disorder, I do not believe this is a legitimate concern
doi: 10.3389/fendo.2024.1431292 Received 11 May 2024 Accepted 08 July 2024 Published 24 July 2024 Volume 15 - 2024 Edited by Hisamitsu Ishihara, Nihon University, Japan Reviewed by Alessandro Pocai, Janssen Research and Development, United States Hiroshi Nomoto, Hokkaido University Hospital, Japan Updates Copyright 2024 Liu